Review:
Non Nucleoside Reverse Transcriptase Inhibitors (nnrtis)
overall review score: 4
⭐⭐⭐⭐
score is between 0 and 5
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a class of antiretroviral drugs used primarily in the treatment of HIV-1 infection. They work by directly binding to the reverse transcriptase enzyme, inhibiting its activity and thereby preventing the replication of the virus. NNRTIs are often used in combination with other antiretrovirals to improve efficacy and reduce resistance development.
Key Features
- Directly target and inhibit HIV-1 reverse transcriptase enzyme
- Non-nucleoside mechanism of action, binding at a different site than NRTIs
- Typically administered orally as part of combination therapy
- Includes drugs such as efavirenz, nevirapine, etravirine, delavirdine, and rilpivirine
- Used to suppress viral load and improve immune function in people living with HIV
Pros
- Effective in reducing viral load when used appropriately
- Usually well-tolerated with manageable side effects
- Available in oral formulations for convenient administration
- Part of combination strategies that lower resistance risk
Cons
- Potential for development of resistance if used improperly
- Some NNRTIs can cause adverse effects such as rash, liver toxicity, or central nervous system symptoms
- Drug interactions may complicate therapy regimens
- Not suitable as monotherapy due to resistance concerns